\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/c\ \(14\)\
\-\ initial\\ multiple\\ mr\\ images\\ demonstrate\\ a\\ ring\\-enhancing\\ lesion\\ in\\ the\\ site\\ of\\ glioma\\,\\ previously\\ treated\\ with\\ radiation\\ therapy\\,\\ with\\ some\\ areas\\ of\\ nodular\\ changes\\.\\ \\ \ \(0\)\
\-\ mr\\ spectroscopy\\ of\\ normal\\ site\\,\\ te\\ \\=\\ 144\\ msec\\,\\ which\\ demonstrates\\ prominent\\ n\\-acetylaspartate\\ \\(naa\\)\\ peak\\ at\\ the\\ 2\\.0\\ ppm\\,\\ which\\ is\\ the\\ normal\\ neuronal\\ marker\\.\\ \\ creatine\\ peak\\ at\\ 3\\.0\\ ppm\\ and\\ choline\\ peak\\ at\\ 3\\.2\\ ppm\\ are\\ also\\ demonstrated\\,\\ showing\\ normal\\ relationships\\.\ \(0\)\
\-\ mr\\ spectroscopy\\ of\\ the\\ abnormal\\ site\\,\\ te\\ \\=\\ 144\\ msec\\,\\ which\\ demonstrates\\ elevation\\ of\\ the\\ choline\\ peak\\,\\ and\\ the\\ suppression\\ of\\ the\\ naa\\ peak\\,\\ along\\ with\\ an\\ inverted\\ peak\\ at\\ the\\ 1\\.0\\-1\\.2\\ ppm\\,\\ which\\ is\\ the\\ lactate\\ peak\\ \\(which\\ characteristically\\ inverts\\ at\\ te\\ \\=\\ 144\\ msec\\)\\.\\ \\ these\\ findings\\ suggest\\ tumor\\ recurrence\\ with\\ some\\ areas\\ of\\ necrosis\\,\\ rather\\ than\\ radiation\\-induced\\ changes\\.\ \(0\)\
\-\ recurrent\\ high\\-grade\\ astrocytoma\ \(0\)\
\-\ \\â\\€\\¢\\ residual\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ recurrent\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ radiation\\ effect\ \(0\)\
\-\ \\â\\€\\¢\\ normal\\ brain\ \(0\)\
\-\ \\â\\€\\¢\\ post\\-operative\\ changes\ \(0\)\
\-\ 38\\ y\\.o\\.\\ white\\ male\\ with\\ previously\\ diagnosed\\ high\\-grade\\ glioma\\ in\\ the\\ left\\ parietal\\ lobe\\,\\ s\\/p\\ radiation\\ treatment\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ peak\\:\\ 0\\.18306410181556718\ \(0\)\
\-\ ppm\\:\\ 0\\.1597682594160561\ \(0\)\
\-\ msec\\:\\ 0\\.14218578103171772\ \(0\)\
\-\ te\\:\\ 0\\.11328643475384585\ \(0\)\
\-\ 144\\:\\ 0\\.10864640132720423\ \(0\)\
\-\ naa\\:\\ 0\\.07552428983589723\ \(0\)\
\-\ choline\\:\\ 0\\.07386675564420629\ \(0\)\
\-\ \\=\\:\\ 0\\.07233524328516398\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.07003154119325218\ \(0\)\
\-\ high\\-grade\\:\\ 0\\.0625783457033603\ \(0\)\
\-\ site\\:\\ 0\\.05825018930467262\ \(0\)\
\-\ 1\\.0\\-1\\.2\\:\\ 0\\.047395260343905905\ \(0\)\
\-\ inverts\\:\\ 0\\.047395260343905905\ \(0\)\
\-\ radiation\\:\\ 0\\.04522985886390865\ \(0\)\
\-\ mr\\:\\ 0\\.04379353987010377\ \(0\)\
\-\ n\\-acetylaspartate\\:\\ 0\\.04366866259895997\ \(0\)\
\-\ which\\:\\ 0\\.04288023083985346\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.04212404170956688\ \(0\)\
\-\ radiation\\-induced\\:\\ 0\\.04148874266289456\ \(0\)\
\-\ glioma\\:\\ 0\\.04142659993232894\ \(0\)\
\-\ relationships\\:\\ 0\\.039942064854014026\ \(0\)\
\-\ changes\\:\\ 0\\.03950077381024291\ \(0\)\
\-\ recurrent\\:\\ 0\\.03877454054973202\ \(0\)\
\-\ creatine\\:\\ 0\\.038742368341572034\ \(0\)\
\-\ previously\\:\\ 0\\.03859969623928277\ \(0\)\
\-\ ring\\-enhancing\\:\\ 0\\.03403554717300268\ \(0\)\
\-\ inverted\\:\\ 0\\.03403554717300268\ \(0\)\
\-\ neuronal\\:\\ 0\\.03248886936412214\ \(0\)\
\-\ lactate\\:\\ 0\\.03216293053715206\ \(0\)\
\-\ tumor\\:\\ 0\\.03213277905823889\ \(0\)\
\-\ n\\/c\\:\\ 0\\.03185562723693728\ \(0\)\
\-\ 3\\.2\\:\\ 0\\.03185562723693728\ \(0\)\
\-\ characteristically\\:\\ 0\\.031564943251613214\ \(0\)\
\-\ suppression\\:\\ 0\\.03128917285168015\ \(0\)\
\-\ at\\:\\ 0\\.031122665398699813\ \(0\)\
\-\ areas\\:\\ 0\\.030917711518774912\ \(0\)\
\-\ 2\\.0\\:\\ 0\\.030308949428056734\ \(0\)\
\-\ marker\\:\\ 0\\.02987861229002697\ \(0\)\
\-\ normal\\:\\ 0\\.02880886999137852\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.028436332792206115\ \(0\)\
\-\ some\\:\\ 0\\.027902454342653326\ \(0\)\
\-\ post\\-operative\\:\\ 0\\.026582351683110794\ \(0\)\
\-\ 38\\:\\ 0\\.024477626596371954\ \(0\)\
\-\ residual\\:\\ 0\\.02280004002937159\ \(0\)\
\-\ elevation\\:\\ 0\\.02269031491307478\ \(0\)\
\-\ rather\\:\\ 0\\.021838323832581365\ \(0\)\
\-\ showing\\:\\ 0\\.021143637104194233\ \(0\)\
\-\ demonstrates\\:\\ 0\\.020071195716700928\ \(0\)\
\-\ recurrence\\:\\ 0\\.020042591874914594\ \(0\)\
\-\ parietal\\:\\ 0\\.0196275938174354\ \(0\)\
\-\ suggest\\:\\ 0\\.019566498340820804\ \(0\)\
\-\ nodular\\:\\ 0\\.01927102046834361\ \(0\)\
\-\ s\\/p\\:\\ 0\\.01927102046834361\ \(0\)\
\-\ \\,\\:\\ 0\\.018920595977014707\ \(0\)\
\-\ prominent\\:\\ 0\\.018856186701963942\ \(0\)\
\-\ necrosis\\:\\ 0\\.01813495007228336\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.017840592465985464\ \(0\)\
\-\ diagnosed\\:\\ 0\\.016893522348360245\ \(0\)\
\-\ effect\\:\\ 0\\.016266442220802393\ \(0\)\
\-\ white\\:\\ 0\\.015237119423182892\ \(0\)\
\-\ initial\\:\\ 0\\.015223559910103808\ \(0\)\
\-\ along\\:\\ 0\\.015183085359454389\ \(0\)\
\-\ brain\\:\\ 0\\.013824470555391195\ \(0\)\
\-\ treated\\:\\ 0\\.01375188621550462\ \(0\)\
\-\ demonstrated\\:\\ 0\\.013480752593854664\ \(0\)\
\-\ y\\.o\\:\\ 0\\.013260104476272582\ \(0\)\
\-\ abnormal\\:\\ 0\\.013102646453305975\ \(0\)\
\-\ lobe\\:\\ 0\\.012361964236148033\ \(0\)\
\-\ therapy\\:\\ 0\\.012283015033551684\ \(0\)\
\-\ than\\:\\ 0\\.012037897069453086\ \(0\)\
\-\ these\\:\\ 0\\.01195615425783785\ \(0\)\
\-\ demonstrate\\:\\ 0\\.01057232334050022\ \(0\)\
\-\ findings\\:\\ 0\\.009778693203171826\ \(0\)\
\-\ multiple\\:\\ 0\\.00967637636279177\ \(0\)\
\-\ lesion\\:\\ 0\\.00935782379570137\ \(0\)\
\-\ treatment\\:\\ 0\\.009299015911832726\ \(0\)\
\-\ also\\:\\ 0\\.00905709458962447\ \(0\)\
\-\ images\\:\\ 0\\.008813246730910506\ \(0\)\
\-\ male\\:\\ 0\\.008307556655308997\ \(0\)\
\-\ \\(\\:\\ 0\\.007767330389718931\ \(0\)\
\-\ \\)\\:\\ 0\\.0076724483022936035\ \(0\)\
\-\ the\\:\\ 0\\.007432757242130419\ \(0\)\
\-\ an\\:\\ 0\\.006353036904756613\ \(0\)\
\-\ are\\:\\ 0\\.006262762755535493\ \(0\)\
\-\ is\\:\\ 0\\.006046137401986298\ \(0\)\
\-\ left\\:\\ 0\\.005140350910069434\ \(0\)\
\-\ in\\:\\ 0\\.004531153012260806\ \(0\)\
\-\ of\\:\\ 0\\.0043845516429350485\ \(0\)\
\-\ with\\:\\ 0\\.0031452735508034875\ \(0\)\
\-\ a\\:\\ 0\\.0021322569990247383\ \(0\)\
\-\ and\\:\\ 0\\.001935580706798048\ \(0\)\
\-\ \\.\\:\\ 0\\.0013360040466743222\ \(0\)\
